Results 21 to 30 of about 100,711 (219)
Guillain-Barre syndrome in 220 patients with COVID-19
The Egyptian Journal of Neurology Psychiatry and Neurosurgery, 2021 This review summarises and discusses recent findings concerning the pathophysiology, clinical presentation, diagnosis, treatment, and outcome of SARS-CoV-2-associated Guillain-Barre syndrome (SC2-GBS).
J. Finsterer, F. Scorza
semanticscholar +1 more source
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
medRxiv, 2020 Background Reports of Guillain-Barre Syndrome (GBS) have emerged during the Coronavirus Disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to investigate any causative association between COVID-19 infection and GBS.
S. Keddie +41 more
semanticscholar +1 more source
BMJ Case Reports, 2021 Prevention strategies for COVID-19 transmission are at the forefront of healthcare paradigms worldwide, the main emphasis of which is vaccination. We present an interesting case of a 37-year-old man who, 3 weeks following his first dose of the chimpanzee
Shreena Patel +3 more
semanticscholar +1 more source
Guillain-Barré syndrome after COVID-19 vaccination
BMJ Case Reports, 2021 We report a case of Guillain-Barré syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID-19 vaccine AstraZeneca).
Norma McKean, Charmaine Chircop
semanticscholar +1 more source
Diagnosis and management of Guillain–Barré syndrome in ten steps
Nature Reviews Neurology, 2019 Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases,
S. Leonhard +20 more
semanticscholar +1 more source
Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects
Nature Reviews Neurology, 2021 The epidemiology, clinical characteristics, management and outcome of Guillain–Barré syndrome (GBS) differ between low-income and middle-income countries (LMIC) and high-income countries (HIC).
Nowshin Papri +5 more
semanticscholar +1 more source
Case of Guillain-Barré syndrome following COVID-19 vaccine
BMJ Case Reports, 2021 Guillain-Barré syndrome (GBS) is a rare immune-mediated disorder of the peripheral nerves. Although its cause is not fully understood, the syndrome often follows infection with a virus or bacteria, although in rare occasions, vaccination may precede GBS.
T. Hasan +3 more
semanticscholar +1 more source
Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2021 : Background: In January 2020, the first case of Guillain Barre syndrome (GBS) due to COVID-19 was documented in China. GBS is known to be postinfectious following several types of infections.
M. Aladawi +6 more
semanticscholar +1 more source
Revista Brasileira de Anestesiologia, 2005 JUSTIFICATIVA E OBJETIVOS: A síndrome de Guillain-Barré após vacina de sarampo é rara. O diagnóstico muitas vezes é tardio, o que leva a um aumento da morbidade.
Deoclécio Tonelli +5 more
doaj +1 more source
Нервно-мышечные болезни, 2020 Introduction. The heterogeneity of the forms and severity of Guillain-Barre syndrome explains the variability of recovery: from rapid and complete (in most cases) to slow with the development of persistent residual deficiency (rarely).
D. A. Grishina, N. A. Suponeva
doaj +1 more source